If you have ever wondered whether Sarepta Therapeutics is actually a bargain right now, you are in the right place for a fresh perspective on its true value. Despite a 6.7% gain in the last week, ...

Charles Schwab's stock narrative has shifted as the consensus analyst price target rose slightly from $111.50 to $111.95.

From about 10:30 p.m. Sunday to 2 a.m. Monday, firefighters battled to keep a major fire under control at the Global Recycling Center in Dededo. Multiple tires and vehicles along the main road were on ...